Evaluating 18F-16 beta-fluoro-5 alpha-dihydrotestosterone (FDHT) and FDG PET as prognostic biomarkers for patients (pts) treated with abiraterone acetate (AA) Meeting Abstract


Authors: Feldman, J. L.; Fox, J. J.; Autio, K. A.; Gavane, S. C.; Heller, G.; Schoder, H.; Humm, J.; Martinez, D. F.; Slovin, S. F.; Scher, H. I.; Larson, S. M.; Morris, M. J.
Abstract Title: Evaluating 18F-16 beta-fluoro-5 alpha-dihydrotestosterone (FDHT) and FDG PET as prognostic biomarkers for patients (pts) treated with abiraterone acetate (AA)
Meeting Title: 2014 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 32
Issue: 4 Suppl.
Meeting Dates: 2014 Jan 30-Feb 1
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2014-02-01
Language: English
ACCESSION: WOS:000335318100059
PROVIDER: wos
Notes: Meeting Abstract: 56 -- Genitourinary Cancers Symposium -- JAN 30-FEB 01, 2014 -- San Francisco, CA -- S -- Source: Wos
MSK Authors
  1. Josef J Fox
    44 Fox
  2. Glenn Heller
    291 Heller
  3. Susan Slovin
    184 Slovin
  4. Michael Morris
    274 Morris
  5. Karen Anne Autio
    42 Autio
  6. Heiko Schoder
    285 Schoder
  7. Somali C Gavane
    12 Gavane
  8. John Laurence Humm
    339 Humm
  9. Steven M Larson
    762 Larson
  10. Howard Scher
    816 Scher
  11. Jarett Lawrence Feldman
    10 Feldman